ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Sieber Direct Communications At NCI, Reorganizing Offices.

March 31, 2000

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

February 12, 1988

Smokers Quitlines Found Effective Regardless of Recruitment Method

June 24, 2011